PAR18 A FIVE-YEAR LONGITUDINAL ANALYSIS COMPARING DOSE CHANGES FOR PATIENTS WITH RHEUMATOID ARTHRITIS TAKING INFLIXIMAB IN A MEDICARE AND IN A COMMERCIALLY INSURED POPULATION
May 1, 2007, 00:00 AM
10.1016/S1098-3015(10)68910-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)68910-3/fulltext
Section Title :
Section Order :
89
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68910-3&doi=10.1016/S1098-3015(10)68910-3